¼¼°èÀÇ DNA ÃßÃâ ŰƮ ½ÃÀå
DNA Extraction Kits
»óǰÄÚµå : 1733493
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 05¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 341 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,496,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 25,489,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

DNA ÃßÃâ ŰƮ ¼¼°è ½ÃÀåÀº 2030³â±îÁö 22¾ï ´Þ·¯¿¡ µµ´Þ

2024³â¿¡ 16¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â DNA ÃßÃâ ŰƮ ¼¼°è ½ÃÀåÀº 2024-2030³â°£ CAGR 5.8%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 22¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ¹«¼¼Æ÷ DNA´Â CAGR 5.0%¸¦ ³ªÅ¸³»°í, ºÐ¼® ±â°£ Á¾·á±îÁö 13¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À¯Àüü DNA ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£¿¡ CAGR 6.7%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 4¾ï 2,880¸¸ ´Þ·¯·Î ÃßÁ¤µÇ´Â ÇÑÆí, Áß±¹Àº CAGR 9.0%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµÈ´Ù

¹Ì±¹ÀÇ DNA ÃßÃâ ŰƮ ½ÃÀåÀº 2024³â¿¡´Â 4¾ï 2,880¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 4¾ï 4,310¸¸ ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 9.0%·Î ÃßÁ¤µË´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î¼­´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£Áß CAGRÀº °¢°¢ 2.9%¿Í 5.7%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 3.8%·Î Àü¸ÁµË´Ï´Ù.

¼¼°èÀÇ DNA ÃßÃâ ŰƮ ½ÃÀå-ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

¿Ö DNA ÃßÃâ ŰƮ°¡ ¿¬±¸, ÀÓ»ó, »ê¾÷ ÀÀ¿ë¿¡ ÇʼöÀûÀΰ¡?

DNA ÃßÃâ ŰƮ´Â Ç÷¾×, Á¶Á÷, ½Ä¹°, ¹ÚÅ׸®¾Æ, ¹ýÀÇÇÐ Áõ°Å µî ´Ù¾çÇÑ »ý¹°ÇÐÀû »ùÇÿ¡¼­ °íǰÁú DNA¸¦ ºÐ¸®Çϴ ǥÁØÈ­µÈ ¹æ¹ýÀ» Á¦°øÇÏ´Â ºÐÀÚ»ý¹°Çп¡¼­ »ç¿ëµÇ´Â ±âº» µµ±¸ÀÔ´Ï´Ù. ÀÌ Å°Æ®´Â ¿ëÇØ ¿ÏÃæ¾×, Á¤Á¦ Ä÷³ ¶Ç´Â ¸¶±×³×ƽ ºñµå, È¿¼Ò ½Ã½ºÅÛÀ» Áï½Ã »ç¿ë °¡´ÉÇÑ ÇüÅ·Π°áÇÕÇÏ¿© ½ÇÇè½Ç ¿öÅ©Ç÷ο츦 °£¼ÒÈ­ÇÕ´Ï´Ù. ÀÌ Å°Æ®´Â À¯Àüü ¿¬±¸, Áø´Ü Å×½ºÆ®, ÀǾàǰ °³¹ß, ¹ýÀÇÇÐ, ³ó¾÷ µî ´Ù¾çÇÑ ºÐ¾ß¿¡ ÇʼöÀûÀÔ´Ï´Ù.

À¯Àüü ¿¬±¸¿Í °³ÀÎ ¸ÂÃãÇü ÀÇ·á°¡ ±ÞÁõÇÔ¿¡ µû¶ó Á¤È®ÇÏ°í ¿À¿°µÇÁö ¾ÊÀº DNA ÃßÃâÀÇ Çʿ伺ÀÌ Å©°Ô Áõ°¡Çϰí ÀÖ½À´Ï´Ù. Çмú ¹× ÀÓ»ó ½ÇÇè½Ç¿¡¼­´Â ÀçÇö¼ºÀ» º¸ÀåÇϰí, 󸮷®À» ´Ã¸®¸ç, »ùÇà ó¸® ½Ã°£À» ´ÜÃàÇϱâ À§ÇØ »ó¿ë ŰƮ¿¡ ´ëÇÑ ÀÇÁ¸µµ°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ´ë±Ô¸ð ½ÇÇè½Ç°ú º´¿ø¿¡¼­ ÀÚµ¿È­µÈ ÇÙ»ê ÃßÃâ Ç÷§ÆûÀÌ µîÀåÇϸ鼭 ÃÖ¼ÒÇÑÀÇ ¼öµ¿ °³ÀÔÀ¸·Î ¾ÈÁ¤ÀûÀÎ ¼öÀ²À» Á¦°øÇϴ ȣȯ °¡´ÉÇÑ ÀÚµ¿È­ Áö¿ø ÃßÃâ ŰƮ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

»ùÇà À¯Çü Ä¿¹ö¸®Áö¿Í ÀÚµ¿È­ ºÐ¾ßÀÇ ±â¼ú Çõ½ÅÀÌ ½ÃÀåÀ» ¾î¶»°Ô º¯È­½Ã۰í Àִ°¡?

ÃÖ±Ù DNA ÃßÃâ ±â¼úÀÇ Çõ½ÅÀº »ùÇà À¯ÇüÀÇ È£È¯¼ºÀ» È®´ëÇϰí ÀÚµ¿È­¸¦ ÅëÇØ È¿À²¼ºÀ» ³ôÀÌ´Â µ¥ ÃÊÁ¡À» ¸ÂÃß¾ú½À´Ï´Ù. ÷´Ü ŰƮ´Â ÇöÀç Æ÷¸£¸»¸° °íÁ¤ ÆÄ¶óÇÉ Æ÷¸Å(FFPE) Á¶Á÷, ¹ýÀÇÇÐÀû »À Á¶°¢ ¶Ç´Â °í´ë DNA¿Í °°Àº ¾î·Á¿î ½Ã·á À¯Çü¿¡ ´ëÇØ DNAÀÇ ¹«°á¼ºÀ» À¯ÁöÇϸ鼭 ¼öÀ²À» ±Ø´ëÈ­Çϴ Ư¼ö È­Çй°ÁúÀ» »ç¿ëÇÏ¿© ´ëÀÀÇϰí ÀÖ½À´Ï´Ù. ¸¶±×³×ƽ ºñµå ±â¹Ý ŰƮ´Â È®À强°ú ÀÚµ¿È­ Ç÷§Æû°úÀÇ È£È¯¼ºÀ¸·Î ÀÎÇØ Àα⸦ ¾ò°í ÀÖ½À´Ï´Ù.

º¥´õµéÀº ¶ÇÇÑ Àü»çüÇÐ ¹× ¸ÞŸÀ¯Àüü°ú °°Àº ´Ù¿î½ºÆ®¸² ¿ëµµ¸¦ °£¼ÒÈ­Çϱâ À§ÇØ DNA/RNA °øµ¿ ÃßÃâ ÇÁ·ÎÅäÄÝÀ» ÅëÇÕÇÑ Å°Æ®¸¦ µµÀÔÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ´ÜÀÏ ¼¼Æ÷ ¹× ÀúÅõÀÔ Å°Æ®´Â Èñ±Í ¼¼Æ÷ Áý´Ü ¹× ¸¶ÀÌÅ©·Î »ùÇøµ Á¶»ç¸¦ °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. ÀÓ»ó Áø´ÜÀÌ ÇöÀå Áø·á ¹× ºÐ»êÇü °Ë»ç·Î ÀüȯµÊ¿¡ µû¶ó, ƯÈ÷ °¨¿°º´ °¨½Ã ¹× ÇöÀå ¿¬±¸¿¡ »ç¿ëÇϱâ À§ÇØ ÇÊ¿äÇÑ ÀÎÇÁ¶ó¸¦ ÃÖ¼ÒÈ­ÇÑ °£¼ÒÈ­µÈ ÈÞ´ë¿ë ÃßÃâ ŰƮ°¡ °³¹ßµÇ°í ÀÖ½À´Ï´Ù.

¼ö¿ä´Â ¾îµð¿¡¼­ ¿À´Â°¡, ±×¸®°í ¾î¶² ºÐ¾ß¿¡¼­ »ç¿ëÀÌ È®´ëµÇ°í Àִ°¡?

³ôÀº 󸮷® ½ÃÄö½Ì ¹× CRISPR °ü·Ã ¿ëµµ¿¡ ÈûÀÔ¾î Çмú ¿¬±¸ ¹× Á¦¾à ¿¬±¸ °³¹ßÀÌ DNA ÃßÃâ ŰƮÀÇ ÁÖ¿ä ¼ö¿äóÀÔ´Ï´Ù. º´¿ø°ú ÀÓ»ó Áø´Ü ½ÇÇè½Çµµ ƯÈ÷ Á¾¾çÇÐ, À¯ÀüÁúȯ ½ºÅ©¸®´×, °¨¿°¼º Áúȯ Áø´Ü ºÐ¾ß¿¡¼­ »ç¿ëÀÚ ¼ö¸¦ ´Ã¸®°í ÀÖ½À´Ï´Ù. ³ó¾÷ »ý¸í°øÇÐ ºÎ¹®Àº ÀÛ¹° À¯Àüü ºÐ¼®, ÇüÁú °³¹ß, º´¿øÃ¼ ³»¼º ¿¬±¸¿¡ DNA ÃßÃâ ŰƮ¸¦ »ç¿ëÇϰí ÀÖ½À´Ï´Ù.

¹ýÀÇÇÐ ¿¬±¸¼Ò, °¡°è Á¶»ç ¾÷ü, ¹ÙÀÌ¿À¹ðÅ© ½Ã¼³¿¡¼­´Â Àå±â º¸°ü ¹× °íÇØ»óµµ ºÐ¼®À» À§ÇØ °í¼øµµ DNA¸¦ ÇÊ¿ä·Î ÇÏ´Â °æ¿ì°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ȯ°æ ¸ð´ÏÅ͸µ ¹× ¹Ì»ý¹° ¿¬±¸¿¡¼­µµ Åä¾ç, Æó¼ö, ´ë±â »ùÇÃÀ» Àü¿ë ŰƮ·Î ÀÏ»óÀûÀ¸·Î ó¸®ÇÏ´Â ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¸ÂÃãÀÇ·á, ÇÕ¼º»ý¹°ÇÐ, ºÐÀÚ¿ªÇÐÀÇ ¼ºÀåÀ¸·Î ½ÃÀåÀÇ ¹üÀ§´Â Àü ¼¼°èÀûÀ¸·Î °è¼Ó È®´ëµÇ°í ÀÖ½À´Ï´Ù.

DNA ÃßÃâ ŰƮ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¿äÀÎÀº ¹«¾ùÀΰ¡?

DNA ÃßÃâ ŰƮ ½ÃÀåÀÇ ¼ºÀåÀº À¯ÀüüÇÐ, ÀÚµ¿È­, Áø´Ü °Ë»çÀÇ º¸±Þ°ú °ü·ÃµÈ ¿©·¯ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ÁÖ¿ä ¿øµ¿·ÂÀº ÀÓ»ó ¹× ¿¬±¸ ȯ°æ Àü¹Ý¿¡¼­ Â÷¼¼´ë ¿°±â¼­¿­ ºÐ¼®(NGS)ÀÇ Ã¤ÅÃÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, À̸¦ À§Çؼ­´Â ³ôÀº ¼öÁØÀÇ ¹«°á¼º DNA Áغñ°¡ ÇÊ¿äÇÕ´Ï´Ù. ½ÅÈï±¹ÀÇ ÀÇ·á ¼­ºñ½º Á¢±Ù¼º ¹× À¯ÀüÀÚ °Ë»ç ´É·ÂÀÇ È®´ëµµ Àú·ÅÇϰí È¿À²ÀûÀΠŰƮ¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

¶ÇÇÑ, ºÐ»êÇü, Æ÷ÀÎÆ® ¿Àºê Äɾî(Point of Care) ºÐÀÚÁø´ÜÀ¸·ÎÀÇ ÀüȯÀÌ °¡¼ÓÈ­µÇ°í ÀÖÀ¸¸ç, ÈÞ´ë¿ë ±â±â¿¡ ´ëÀÀÇÏ´Â °£ÆíÇÑ Å°Æ®°¡ ¿ä±¸µÇ°í ÀÖ½À´Ï´Ù. ÇÕ¼º»ý¹°ÇÐ, ³ó¾÷, ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ºÐ¼®¿¡ ´ëÇÑ ¿¬±¸°³¹ß Áõ°¡´Â ½ÃÀå ±âȸ¸¦ ´õ¿í È®´ë½Ã۰í ÀÖ½À´Ï´Ù. ¸¶Áö¸·À¸·Î, ÀÓ»ó ½ÇÇè½Ç ¹× ¿¬±¸¼ÒÀÇ ÀÚµ¿ ¾×ü ó¸® ½Ã½ºÅÛ ÅëÇÕÀ¸·Î ÀÎÇØ °ø±Þ¾÷üµéÀº È®Àå °¡´ÉÇϰí ÀÚµ¿È­µÈ ÃßÃâ ¼Ö·ç¼ÇÀ» Á¦°øÇÏ°Ô µÇ¾ú°í, ÀÌ´Â Àü³â ´ëºñ Áö¼ÓÀûÀÎ ¼ºÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù.

ºÎ¹®

Á¦Ç° À¯Çü(¹«¼¼Æ÷ DNA, À¯Àüü DNA, ±âŸ Á¦Ç°);¿ëµµ(PCR, ½ÃÄö½Ì, Ŭ·Î´×, ±âŸ ¿ëµµ);»ùÇà À¯Çü(Ç÷¾×/Á¶Á÷/FFPE, ¼¼Æ÷, ±âŸ »ùÇà À¯Çü);ÃÖÁ¾»ç¿ëÀÚ(ÀÇ·á½Ã¼³, Á¦¾à ±â¾÷ ¹× ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷, ¿¬±¸±â°ü, ±âŸ ÃÖÁ¾»ç¿ëÀÚ)

Á¶»ç ´ë»ó ±â¾÷ ¿¹(ÃÑ 41°³»ç)

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ÀÎÀ§ÀûÀÎ ¼öÀÍ¿ø°¡ Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû ¹× °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

Global Industry Analysts´Â ¼¼°è ÁÖ¿ä ¼ö¼® ÀÌÄÚ³ë¹Ì½ºÆ®(1,4,949¸í), ½ÌÅ©ÅÊÅ©(62°³ ±â°ü), ¹«¿ª ¹× »ê¾÷ ´Üü(171°³ ±â°ü)ÀÇ Àü¹®°¡µéÀÇ ÀǰßÀ» ¸é¹ÐÈ÷ °ËÅäÇÏ¿© »ýŰ迡 ¹ÌÄ¡´Â ¿µÇâÀ» Æò°¡ÇÏ°í »õ·Î¿î ½ÃÀå Çö½Ç¿¡ ´ëÀÀÇϰí ÀÖ½À´Ï´Ù. ¸ðµç ÁÖ¿ä ±¹°¡ÀÇ Àü¹®°¡¿Í °æÁ¦ÇÐÀÚµéÀÌ °ü¼¼¿Í ±×°ÍÀÌ ÀÚ±¹¿¡ ¹ÌÄ¡´Â ¿µÇâ¿¡ ´ëÇÑ ÀǰßÀ» ÃßÀû Á¶»çÇß½À´Ï´Ù.

Global Industry Analysts´Â ÀÌ·¯ÇÑ È¥¶õÀÌ ÇâÈÄ 2-3°³¿ù ³»¿¡ ¸¶¹«¸®µÇ°í »õ·Î¿î ¼¼°è Áú¼­°¡ º¸´Ù ¸íÈ®ÇÏ°Ô È®¸³µÉ °ÍÀ¸·Î ¿¹»óÇϰí ÀÖÀ¸¸ç, Global Industry Analysts´Â ÀÌ·¯ÇÑ »óȲÀ» ½Ç½Ã°£À¸·Î ÃßÀûÇϰí ÀÖ½À´Ï´Ù.

2025³â 4¿ù: Çù»ó ´Ü°è

À̹ø 4¿ù º¸°í¼­¿¡¼­´Â °ü¼¼°¡ ¼¼°è ½ÃÀå Àüü¿¡ ¹ÌÄ¡´Â ¿µÇâ°ú Áö¿ªº° ½ÃÀå Á¶Á¤¿¡ ´ëÇØ ¼Ò°³ÇÕ´Ï´Ù. ´ç»çÀÇ ¿¹ÃøÀº °ú°Å µ¥ÀÌÅÍ¿Í ÁøÈ­ÇÏ´Â ½ÃÀå ¿µÇâ¿äÀÎÀ» ±â¹ÝÀ¸·Î ÇÕ´Ï´Ù.

2025³â 7¿ù: ÃÖÁ¾ °ü¼¼ Àç¼³Á¤

¹«·á ¾÷µ¥ÀÌÆ® °¢±¹ÀÇ ÃÖÁ¾ ¸®¼ÂÀÌ ¹ßÇ¥µÈ ÈÄ, 7¿ù¿¡ ¹«·á ¾÷µ¥ÀÌÆ® ¹öÀüÀ» °í°´´Ôµé²² Á¦°øÇØ µå¸³´Ï´Ù. ÃÖÁ¾ ¾÷µ¥ÀÌÆ® ¹öÀü¿¡´Â ¸íÈ®ÇÏ°Ô Á¤ÀÇµÈ °ü¼¼ ¿µÇ⠺м®ÀÌ Æ÷ÇԵǾî ÀÖ½À´Ï´Ù.

»óÈ£ ¹× ¾çÀÚ °£ ¹«¿ª°ú °ü¼¼ÀÇ ¿µÇ⠺м® :

¹Ì±¹ÀÇ <>& Áß±¹ <>& ¸ß½ÃÄÚ <>& ij³ª´Ù <>&EU <>& ÀϺ» <>& Àεµ <>& ±âŸ 176°³±¹

¾÷°è ÃÖ°íÀÇ ÀÌÄÚ³ë¹Ì½ºÆ®: Global Industry AnalystsÀÇ Áö½Ä ±â¹ÝÀº ±¹°¡, ½ÌÅ©ÅÊÅ©, ¹«¿ª ¹× »ê¾÷ ´Üü, ´ë±â¾÷, ±×¸®°í ¼¼°è °è·® °æÁ¦ »óȲ¿¡¼­ Àü·Ê ¾ø´Â ÆÐ·¯´ÙÀÓ ÀüȯÀÇ ¿µÇâÀ» °øÀ¯ÇÏ´Â ºÐ¾ßº° Àü¹®°¡ µî °¡Àå ¿µÇâ·Â ÀÖ´Â ÃÖ°í ÀÌÄÚ³ë¹Ì½ºÆ®¸¦ Æ÷ÇÔÇÑ 14,949¸íÀÇ ÀÌÄÚ³ë¹Ì½ºÆ®¸¦ ÃßÀûÇϰí ÀÖ½À´Ï´Ù. 16,491°³ ÀÌ»óÀÇ º¸°í¼­ ´ëºÎºÐ¿¡ ¸¶ÀϽºÅæ¿¡ ±â¹ÝÇÑ 2´Ü°è Ãâ½Ã ÀÏÁ¤ÀÌ Àû¿ëµÇ¾î ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global DNA Extraction Kits Market to Reach US$2.2 Billion by 2030

The global market for DNA Extraction Kits estimated at US$1.6 Billion in the year 2024, is expected to reach US$2.2 Billion by 2030, growing at a CAGR of 5.8% over the analysis period 2024-2030. Cell-free DNA, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$1.3 Billion by the end of the analysis period. Growth in the Genomic DNA segment is estimated at 6.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$428.8 Million While China is Forecast to Grow at 9.0% CAGR

The DNA Extraction Kits market in the U.S. is estimated at US$428.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$443.1 Million by the year 2030 trailing a CAGR of 9.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.9% and 5.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.

Global DNA Extraction Kits Market - Key Trends & Drivers Summarized

Why Are DNA Extraction Kits Essential Across Research, Clinical, and Industrial Applications?

DNA extraction kits are foundational tools used in molecular biology, providing standardized methods for isolating high-quality DNA from various biological samples including blood, tissues, plants, bacteria, and forensic evidence. These kits streamline laboratory workflows by combining lysis buffers, purification columns or magnetic beads, and enzyme systems into ready-to-use formats. They are indispensable across a wide spectrum of applications such as genomics research, diagnostic testing, pharmaceutical development, forensics, and agriculture.

With the surge in genomic research and personalized medicine, the need for accurate, contamination-free DNA extraction has grown significantly. Academic and clinical labs are increasingly relying on commercial kits to ensure repeatability, improve throughput, and reduce sample processing times. Additionally, the rise of automated nucleic acid extraction platforms in large-scale labs and hospitals is amplifying the demand for compatible, automation-ready extraction kits that deliver consistent yields with minimal manual intervention.

How Are Innovations in Sample Type Coverage and Automation Transforming the Market?

Recent innovations in DNA extraction technologies are focused on expanding sample type compatibility and enhancing efficiency through automation. Advanced kits now cater to challenging sample types-such as formalin-fixed paraffin-embedded (FFPE) tissues, forensic bone fragments, or ancient DNA-with specialized chemistries that maximize yield while preserving DNA integrity. Magnetic bead-based kits are gaining popularity due to their scalability and compatibility with automated platforms.

Vendors are also introducing kits with integrated DNA/RNA co-extraction protocols to streamline downstream applications like transcriptomics and metagenomics. Moreover, single-cell and low-input kits are enabling research in rare cell populations and micro-sampling studies. As clinical diagnostics shift toward point-of-care and decentralized testing, simplified and portable extraction kits with minimal infrastructure requirements are being developed, particularly for use in infectious disease surveillance and field research.

Where Is Demand Coming From, and What Sectors Are Scaling Up Usage?

Academic research and pharmaceutical R&D are the primary consumers of DNA extraction kits, driven by high-throughput sequencing and CRISPR-related applications. Hospitals and clinical diagnostic labs also form a growing user base, particularly in oncology, genetic disorder screening, and infectious disease diagnostics. The agricultural biotech sector uses DNA extraction kits for crop genome analysis, trait development, and pathogen resistance studies.

Forensic labs, ancestry companies, and biobanking facilities increasingly require high-purity DNA for long-term storage or high-resolution analysis. Emerging demand is also evident in environmental monitoring and microbiome research, where soil, wastewater, and air samples are routinely processed using specialized kits. Growth in personalized health, synthetic biology, and molecular epidemiology continues to broaden the market’s scope globally.

What Is Fueling the Growth of the DNA Extraction Kits Market?

The growth in the DNA extraction kits market is driven by several factors linked to the proliferation of genomics, automation, and diagnostic testing. A major driver is the rising adoption of next-generation sequencing (NGS) across clinical and research environments, which necessitates high-integrity DNA preparation. Expanding healthcare access and genetic testing capabilities in emerging economies are also fueling demand for affordable, efficient kits.

Another driver is the shift toward decentralized and point-of-care molecular diagnostics, which requires simplified kits compatible with portable instruments. Increasing R&D in synthetic biology, agriculture, and microbiome analysis is further expanding market opportunities. Finally, the integration of automated liquid handling systems in clinical labs and research centers is pushing vendors to offer scalable, automation-ready extraction solutions, driving consistent year-over-year growth.

SCOPE OF STUDY:

The report analyzes the DNA Extraction Kits market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Cell-free DNA, Genomic DNA, Other Products); Application (PCR, Sequencing, Cloning, Other Applications); Sample Type (Blood / Tissue / FFPE, Cells, Other Sample Types); End-User (Healthcare Facilities, Pharma & Biotech Companies, Research Institutes, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â